Development of medical countermeasures through planned clinical trials and outbreak preparedness

Active Definitive Contract Awarded Last action

Contract number
75A50124C00003
Awardee
Awarding agency
Obligated
$5,626,972

Award facts

Opportunity
Contract value 15% obligated
  • $5,626,972.02 Current, with exercised options
  • $38,242,688.02 Potential, with all options
Completion date 30% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
San Diego, CA 92121, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 · Purpose of this no cost MOD is to receive all remaining GOV property barda contract no. HHSO100201600021C for continued use in support of the existing… $0
Supplemental Agreement for work within scope P00012 · The purpose of this supplemental agreement is to: $2,622,474
Other Administrative Action P00011 · The purpose of this no-cost modification is to revise article g.7. Indirect cost rate and 52.222-90 addressing DEI discrimination by federal contractors. $0
Other Administrative Action P00010 · The purpose of the unilateral no cost modification is to designate the alternate COR DR. Saima zaman as the primary COR IAW the executed COR designation… $0
Supplemental Agreement for work within scope P00009 · Supplemental agreement to fund clin 0001 and update statement of work. $43,289
Other Administrative Action P00008 · No cost modification to incorporate approved rates in section g.7. Indirect cost rates. $0
Other Administrative Action P00007 · No cost modification is so contract no. 75A50124C00003 can receive government furnished property (GFP) from contract no. 75A50122C00076 and contract no.… $0
Other Administrative Action P00006 · No cost modification to add a quality agreement, revise the statement of work, and add executive order far clause changes. $0
Other Administrative Action P00005 · Unilateral no cost modification to designate the alternate COR DR. Carol diaz-diaz as the primary COR. Saima zaman will temporarily assume the alternate COR… $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · No cost modification to transfer government furnished property under barda contract no. 75A50122C00076 to barda contract no. 75A50124C00003. $0
Other Administrative Action P00001 · No cost modification to revise indirect rates in section g.7. $0
Original award $2,961,209
Show all 14

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Mapp Biopharmaceutical, Inc. for development of medical countermeasures through planned clinical trials and outbreak preparedness, with a ceiling value of $38.2 million and an ultimate completion date of December 31, 2032. The award, dated March 20, 2024, incorporates remaining government property from BARDA contract HHSO100201600021C for continued use under this contract. Pricing is cost-plus-fixed-fee with no set-aside.

Place of performance is San Diego, CA. The originating Broad Agency Announcement, posted October 16, 2017, solicited advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear and pandemic influenza threats, including vaccines, therapeutics, diagnostics, and production platforms advancing candidates toward FDA approval or licensure.

In FY2024, the contract invoiced $62 thousand across 0.1 FTEs and 180 contractor hours at a derived government-paid rate of $343.18 per hour. Subcontractor engagement included one subcontractor in that fiscal year. Mapp performs monoclonal antibody and recombinant antigen development and manufacturing; this award continues clinical trial and preparedness work on infectious disease and biological threat countermeasures.

Quick answers

Who was awarded contract 75A50124C00003?

75A50124C00003 was awarded to Mapp Biopharmaceutical, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 20, 2024.

How much is contract 75A50124C00003 worth?

The government has obligated $5,626,972 on 75A50124C00003. Its potential value, with all options, is $38,242,688.

Was contract 75A50124C00003 competed?

The extent of competition for 75A50124C00003 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login